Johnson & Johnson (Extended Hours)Johnson & Johnson (Extended Hours)Johnson & Johnson (Extended Hours)

Johnson & Johnson (Extended Hours)

No trades
See on Supercharts

Key facts today


Johnson & Johnson (JNJ) rose 2.9% during a market selloff, as investors favored consumer staples and pharmaceuticals, indicating a shift towards defensive sectors amid economic uncertainty.
Johnson & Johnson's drug Tremfya met key goals in a phase 3 study for active psoriatic arthritis, reducing symptoms and structural damage at 24 weeks, with no new safety issues.
Wells Fargo has raised its price target for Johnson & Johnson (JNJ) to $170 from $152, while keeping an equal-weight rating on the stock.
Analyze the impactAnalyze the impact

About Johnson & Johnson


Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

See all ideas 

Displays a symbol's price movements over previous years to identify recurring trends.